Your session is about to expire
← Back to Search
Auditory Feedback for Gait Improvement
N/A
Waitlist Available
Led By Dobromir Dotov, PhD
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the time frame to measure changes in the outcome variable is two weeks, from the first to last measurement. the time frame to obtain one sample is a few minutes of walking.
Awards & highlights
Study Summary
This trial will explore the role of sound in movement stability, by testing if restricting or augmenting auditory feedback from footsteps can improve movement. Eligibility based on incl/excl criteria (19-35, no hearing/mobility/neurological impairments). 5 visits in 2wks, 1st & last for pre/post comparison.
Who is the study for?
This trial is for individuals who can exercise for 30 minutes and walk comfortably for the same duration. It's not suitable for pregnant women, those with back or leg injuries, surgeries affecting mobility, neurological issues that limit walking ability, or known hearing or visual impairments.Check my eligibility
What is being tested?
The study investigates how sounds made during activities like walking influence movement stability and adaptability. Participants' auditory feedback from their footsteps will be either restricted or augmented to see if it improves their gait.See study design
What are the potential side effects?
Since this trial involves non-invasive auditory feedback manipulation rather than medication or surgery, significant side effects are not anticipated. However, some participants might experience discomfort with altered hearing of their footsteps.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ the time frame to measure changes in the outcome variable is two weeks, from the first to last measurement. the time frame to obtain one sample is a few minutes of walking.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the time frame to measure changes in the outcome variable is two weeks, from the first to last measurement. the time frame to obtain one sample is a few minutes of walking.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Gait instability measured with the maximum Lyapunov exponent (MLE)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Walking QuietlyExperimental Treatment1 Intervention
Participants instructed to make little noise while walking.
Group II: WalkingActive Control1 Intervention
Walking normally without restriction
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Auditory Feedback
2020
Completed Early Phase 1
~30
Find a Location
Who is running the clinical trial?
University of NebraskaLead Sponsor
541 Previous Clinical Trials
1,144,733 Total Patients Enrolled
Dobromir Dotov, PhDPrincipal InvestigatorUniversity of Nebraska
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can comfortably walk for 30 minutes.I have a history of injuries or conditions that affect my ability to walk.I have a known hearing or visual impairment.
Research Study Groups:
This trial has the following groups:- Group 1: Walking
- Group 2: Walking Quietly
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger